World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 36

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1634)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series.

Item

Count

PDF

HTML

486

Figures (1-8)

Sum=628

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

418

Download

452

Sum=870

Sep 28, 2025 (publication date) through Apr 11, 2026

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	He Y, Liu J, Zhou N, Xie LX, Jiang YF, Chen CL. Peroxiredoxin 1 inhibits tumorigenesis by activating the NLRP3/GSDMD pathway to induce pyroptosis of colorectal cancer cells. World J Gastroenterol 2025; 31(36): 111557 [PMID: 41025079 DOI: 10.3748/wjg.v31.i36.111557]
URL:	https://www.wjgnet.com/1007-9327/full/v31/i36/111557.htm

Number	Citing Articles
1	Yu-Gang Wang, Wen-Ying Meng, Jia-Wei Zhao, Zi-Ke Chen. Peroxiredoxin 1 as a novel pyroptosis inducer in colorectal cancer: Insights and future directions. World Journal of Gastroenterology 2026; 32(8): 116016 doi: 10.3748/wjg.v32.i8.116016 Abstract(27) \| Core Tip(22) \| Full Article(HTML)(217) \| Full Article with Cover (PDF)-707K(28) \| Audio-736K(6) \| Peer-Review Report-189K(17) \| Answering Reviewers-186K(14) \| Full Article (PDF)-352K(46) \| Full Article (XML)-40K(13) \| Times Cited (0) \| Total Visits (693) \| Open
2	Dharmendra Kumar Maurya. Peroxiredoxin 1, pyroptosis, and the emerging frontier in colorectal cancer therapy. World Journal of Gastroenterology 2026; 32(1): 114184 doi: 10.3748/wjg.v32.i1.114184 Abstract(42) \| Core Tip(49) \| Full Article(HTML)(169) \| Full Article with Cover (PDF)-1079K(40) \| Audio-865K(10) \| Peer-Review Report-275K(28) \| Answering Reviewers-107K(28) \| Full Article (PDF)-383K(53) \| Full Article (XML)-55K(17) \| Times Cited (1) \| Total Visits (1325) \| Open
3	Ilya D Klabukov, Denis S Baranovskii, Irina Kondrasheva, Daria Eygel, Anna Smirnova. Peroxiredoxin 1 inhibits tumorigenesis by activating the NLR family pyrin domain containing 3/gasdermin D pathway: Advanced therapies targeting heterogeneous cell death mechanisms. World Journal of Gastroenterology 2025; 31(44): 114404 doi: 10.3748/wjg.v31.i44.114404 Abstract(53) \| Core Tip(51) \| Full Article(HTML)(185) \| Full Article with Cover (PDF)-691K(37) \| Audio-62K(6) \| Peer-Review Report-345K(18) \| Answering Reviewers-161K(25) \| Full Article (PDF)-361K(42) \| Full Article (XML)-39K(22) \| Times Cited (0) \| Total Visits (956) \| Open
4	Yosup Kim, Eun-Kyung Kim, Ho Hee Jang. Moonlighting Functions of Mammalian Peroxiredoxins in Cellular Signaling. Antioxidants 2026; 15(2): 231 doi: 10.3390/antiox15020231